24 HR Alprazolam 0.5 MG Extended Release Oral Tablet
INDICATIONS AND USAGE Alprazolam extended-release tablets are indicated for the treatment of panic disorder, with or without agoraphobia. This claim is supported on the basis of two positive studies with alprazolam extended-release tablets conducted in patients whose diagnoses corresponded closely to the DSM-III-R/IV criteria for panic disorder (see CLINICAL EFFICACY TRIALS ). Panic disorder (DSM-IV) is characterized by recurrent unexpected panic attacks, i.e., a discrete period of intense fear or discomfort in which four (or more) of the following symptoms develop abruptly and reach a peak within 10 minutes: (1) palpitations, pounding heart, or accelerated heart rate; (2) sweating; (3) trembling or shaking; (4) sensations of shortness of breath or smothering; (5) feeling of choking; (6) chest pain or discomfort; (7) nausea or abdominal distress; (8) feeling dizzy, unsteady, lightheaded, or faint; (9) derealization (feelings of unreality) or depersonalization (being detached from oneself); (10) fear of losing control; (11) fear of dying; (12) paresthesias (numbness or tingling sensations); (13) chills or hot flushes. The longer-term efficacy of alprazolam extended-release tablets has not been systematically evaluated. Thus, the physician who elects to use this drug for periods longer than 8 weeks should periodically reassess the usefulness of the drug for the individual patient.
Mylan Pharmaceuticals Inc.
ROUND WHITE M A21
Related Pills
alprazolam 1 MG 24 HR Extended Release Tablet
Mylan Pharmaceuticals Inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED Alprazolam Extended-release Tablets, USP are available containing 0.5 mg, 1 mg, 2 mg or 3 mg of alprazolam, USP. The 0.5 mg tablets are white to off-white, round, unscored tablets debossed with M on one side of the tablet and A21 on the other side. They are available as follows: NDC 0378-5021-91 bottles of 60 tablets NDC 0378-5021-05 bottles of 500 tablets The 1 mg tablets are light orange, round, unscored tablets debossed with M on one side of the tablet and A22 on the other side. They are available as follows: NDC 0378-5022-91 bottles of 60 tablets NDC 0378-5022-05 bottles of 500 tablets The 2 mg tablets are light Lavender, round, unscored tablets debossed with M on one side of the tablet and A23 on the other side. They are available as follows: NDC 0378-5023-91 bottles of 60 tablets NDC 0378-5023-05 bottles of 500 tablets The 3 mg tablets are light pink, round, unscored tablets debossed with M on one side of the tablet and A24 on the other side. They are available as follows: NDC 0378-5024-91 bottles of 60 tablets NDC 0378-5024-05 bottles of 500 tablets Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.
More pills like ROUND M A21